|Bid||78.94 x 800|
|Ask||79.01 x 800|
|Day's range||78.69 - 80.76|
|52-week range||62.63 - 87.49|
|Beta (5Y monthly)||0.47|
|PE ratio (TTM)||118.30|
|Forward dividend & yield||0.11 (0.14%)|
|Ex-dividend date||04 May 2021|
|1y target est||85.83|
Segment wise, within Alcon's (ALC) Surgical arm, the portfolio of advanced technology intraocular lenses is driving increased penetration rates of ATIOLs.
Alcon (ALC) records year-over-year growth across all sales categories in Surgical and Vision Care in Q3.
GENEVA, November 10, 2021--Alcon Reports Third Quarter 2021 Results